ALPS Medical Breakthroughs ETF
SBIO
42 hedge funds and large institutions have $45.1M invested in ALPS Medical Breakthroughs ETF in 2018 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 19 increasing their positions, 2 reducing their positions, and 3 closing their positions.
850% more repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 2
267% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 3
111% more call options, than puts
Call options by funds: $1.36M | Put options by funds: $644K
89% more capital invested
Capital invested by funds: $23.9M → $45.1M (+$21.2M)
24% more funds holding
Funds holding: 34 → 42 (+8)
8.25% more ownership
Funds ownership: 17.33% → 25.58% (+8.3%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Barometer Capital Management
Toronto,
Ontario, Canada
|
+$4.5M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$3.78M |
| 3 |
Wells Fargo
San Francisco,
California
|
+$3.61M |
| 4 |
Morgan Stanley
New York
|
+$1.7M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.44M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
-$396K |
| 2 |
FAAS
First Allied Advisory Services
San Diego,
California
|
-$147K |
| 3 |
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
|
-$34.7K |
| 4 |
CA
Calton & Associates
Tampa,
Florida
|
-$20K |
| 5 |
Citigroup
New York
|
-$14.2K |
SBIO Hedge Fund Activity: Q1 2018 in Review
42 of the 4,373 institutional investors tracked by Wall St. Rank reported a position in ALPS Medical Breakthroughs ETF (SBIO) for Q1 2018, worth a combined $45.1M — up 89% from $23.9M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new SBIO positions and 3 closed out — a net gain of 8 holders — while 19 added to existing stakes and 2 trimmed.
The largest buyer was Barometer Capital Management, adding an estimated $4.5M. The largest seller was United Capital Financial Advisors, exiting entirely with an estimated $396K sold.
- 42 institutional investors held ALPS Medical Breakthroughs ETF (SBIO) as of Q1 2018, up from 34 in Q4 2017.
- Funds reported $45.1M of ALPS Medical Breakthroughs ETF stock for Q1 2018, up 89% quarter-over-quarter.
- 11 funds opened new ALPS Medical Breakthroughs ETF positions in Q1 2018 and 3 closed out, a net change of +8 holders.
- The largest ALPS Medical Breakthroughs ETF buyer in Q1 2018 was Barometer Capital Management, an estimated $4.5M added.
- The largest ALPS Medical Breakthroughs ETF seller in Q1 2018 was United Capital Financial Advisors, an estimated $396K sold.
Based on aggregated 13F filings for Q1 2018.